We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Nematode Infection Controls Obesity and Modulates Body Weight and Metabolism

By LabMedica International staff writers
Posted on 09 May 2013
In an interesting combination of low and high technology approaches to the control and treatment of obesity, a recent study suggested that infection with parasitic nematodes (roundworms) could suppress the chronic inflammation associated with obesity and modulate body weight and metabolism.

Obesity is associated with a chronic low-grade inflammation characterized by increased levels of proinflammatory cytokines that are implicated in metabolic dysfunction. More...
Nematode infection, which elevates host immune Th2-cells and related type two cytokines, has been used in ancient medicine and is currently under clinical investigation for treatment for diseases associated with the relevant cytokines, including inflammatory bowel disease, multiple sclerosis, and allergies

Investigators at the University of Maryland School of Medicine (Baltimore, USA) examined the possibility of using nematode infection to treat obesity. They worked with several strains of mice that were fed normal or high-fat diets.

They reported in the March 18, 2013, online edition of the journal Infection and Immunity that normal size mice infected with the nematode Nippostrongyrus brasiliensis fed a high-fat diet gained 15% percent less weight than control animals that were not infected. Mice that were already obese when infected lost roughly 13% of their body weight within 10 days. Infected animals were found to have decreased fasting blood glucose levels and reduced incidence of fatty liver disease.

"The levels of insulin and leptin also dropped, indicating that the mice restored their sensitivities to both hormones," said senior author Dr. Aiping Zhao, associate professor of radiation oncology at the University of Maryland School of Medicine. "Leptin moderates appetite. As with too much insulin, too high a level of leptin results in insensitivity, thus contributing to obesity and metabolic syndrome."

Related Links:

University of Maryland School of Medicine



Gold Member
Neonatal Heel Incision Device
Tenderfoot
Online QC Software
Acusera 24•7
Automatic CLIA Analyzer
Shine i6000
Steam Sterilizer
Hi Vac II Line
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Characterization of EV separated by distinct methods (Photo courtesy of Yuanyuan Liu, Yanbin Guo et al. Engineering, doi.org/10.1016/j.eng.2025.12.009)

Liquid Biopsy Biomarkers May Improve Childhood Epilepsy Diagnosis

Childhood epilepsy remains a major neurological disorder with unmet needs for accurate, non-invasive biomarkers, as conventional tests such as electroencephalography and neuroimaging can have limited sensitivity... Read more

Molecular Diagnostics

view channel
Image: NeoCircle Study Synopsis (George, A.M., Chen, Y., Gladchuk, S. et al. EMBO Molecular Medicine (2026). DOI: 10.1038/s44321-026-00447-z)

Ultrasensitive MRD Blood Test Detects Early Breast Cancer Recurrence

SAGA Diagnostics (Morrisville, NC, USA), a company specializing in tumor-informed, blood-based cancer detection and precision medicine, announced the publication of a new study evaluating its Pathlight... Read more

Pathology

view channel
Image: Immune-related signals in routine bone marrow biopsy slides could help predict multiple myeloma outcomes and support more personalized treatment strategies (image credit: Shutterstock)

AI Tool Extracts Immune Signals from Biopsy to Inform Myeloma Therapy

Multiple myeloma is a bone marrow malignancy in which patients can respond very differently to the same treatments, making initial therapy decisions difficult. Clinicians must choose among options such... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.